Sonographic Monitoring of Growth of Uterine Myomas in Untreated Women and Respective Influence Factors

Abstract

Research Question What are the growth patterns of uterine myomas in untreated premenopausal women? Which factors influence the growth rate of uterine myomas in premenopausal women?

Method All premenopausal women who presented to the outpatient myoma consultation clinic between January 2005 and March 2022 at least twice were screened. Exclusion criteria were hormonal therapy, pregnancy, and postmenopausal status.

Results A total of 189 patients were included in our study which focused on the respective largest uterine myoma of each woman. An ideal linear growth over time was assumed. Most myomas (82%) increased in size. The mean annual growth of these myomas was 68.42 cm³. The most important prognostic factor for growth was the initial size of the myoma. The absolute annual growth of myomas measuring > 50 cm³ at first presentation was higher compared to smaller myomas (p < 0.001). The relative annual growth rate was highest for myomas measuring between 20 and 50 cm³ at the initial presentation (p = 0.003). The relative annual growth rate in women older than 40 years was significantly lower than that in women below the age of 40 years (p = 0.003).

Conclusion Overall, it is difficult to make an individual prognosis about the growth pattern of a uterine myoma in a specific patient. It should be noted especially in asymptomatic patients that spontaneous regression of myoma size can also occur in premenopausal women.

Key words

myoma - fibroid - myoma growth - ultrasound - premenopause - uterus

Publikationsverlauf

Eingereicht: 09. September 2022

Angenommen nach Revision: 01. Dezember 2022

Artikel online veröffentlicht:
05. April 2023

• References/Literatur

• 1 Downes E, Sikirica V, Gilabert-Estelles J. et al. The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol 2010; 152: 96-102
• 2 Utz-Billing I, Rothmann K, Kentenich H. et al. Prätherapeutische Ängste, Erwartungen, Wünsche und Informiertheit von Frauen mit Uterus myomatosus. Geburtshilfe Frauenheilkd 2006; 66: 763-768
• 3 Segars JH, Parrott EC, Nagel JD. et al. Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations. Hum Reprod Update 2014; 20: 309-333
• 4 Istre O. Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy. Best Pract Res Clin Obstet Gynaecol 2008; 22: 735-747
• 5 Ichimura T, Kawamura N, Ito F. et al. Correlation between the growth of uterine leiomyomata and estrogen and progesterone receptor content in needle biopsy specimens. Fertil Steril 1998; 70: 967-971
• 6 Peddada SD, Laughlin SK, Miner K. et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A 2008; 105: 19887-19892
• 7 Davis BJ, Haneke KE, Miner K. et al. The fibroid growth study: determinants of therapeutic intervention. J Womens Health (Larchmt) 2009; 18: 725-732
• 8 Kasai M, Ichimura T, Kawamura N. et al. Prediction of the shrinking rate of uterine leiomyoma nodules using needle biopsy specimens. Fertil Steril 2012; 98: 440-443
• 9 Tsuda H, Kawabata M, Nakamoto O. et al. Clinical predictors in the natural history of uterine leiomyoma: preliminary study. J Ultrasound Med 1998; 17: 17-20
• 10 DeWaay DJ, Syrop CH, Nygaard IE. et al. Natural history of uterine polyps and leiomyomata. Obstet Gynecol 2002; 100: 3-7
• 11 Mavrelos D, Ben-Nagi J, Holland T. et al. The natural history of fibroids. Ultrasound Obstet Gynecol 2010; 35: 238-242
• 12 Moshesh M, Peddada SD, Cooper T. et al. Intraobserver variability in fibroid size measurements: estimated effects on assessing fibroid growth. J Ultrasound Med 2014; 33: 1217-1224
• 13 Nieuwenhuis L, Keizer A, Stoelinga B. et al. Fibroid vascularisation assessed with three-dimensional power Doppler ultrasound is a predictor for uterine fibroid growth: a prospective cohort study. BJOG 2018; 125: 577-584
• 14 Levens ED, Wesley R, Premkumar A. et al. Magnetic resonance imaging and transvaginal ultrasound for determining fibroid burden: implications for research and clinical care. Am J Obstet Gynecol 2009; 200: 537.e1-537.e7
• 15 Diehl K, Alkatout I, Kanzow M. et al. Gutartige Tumoren des Uterus. Gynäkologe 2021; 54: 435-446
• 16 ACOG. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol 2008; 112: 387-400
• 17 Parker WH. Uterine myomas: management. Fertil Steril 2007; 88: 255-271
• 18 Schwartz PE, Kelly MG. Malignant transformation of myomas: myth or reality?. Obstet Gynecol Clin North Am 2006; 33: 183-198 xii
• 19 Parker WH. Uterine Fibroids: clinical Features. In: Tinelli A, Malvasi A. eds. Uterine Myoma, Myomectomy and minimally invasive Treatments. Cham: Springer International Publishing; 2015: 39-52
• 20 Denschlag D, Ackermann S, Battista MJ. et al. Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019). Geburtshilfe Frauenheilkd 2019; 79: 1043-1060
• 21 Testa AC, Di Legge A, Bonatti M. et al. Imaging techniques for evaluation of uterine myomas. Best Pract Res Clin Obstet Gynaecol 2016; 34: 37-53
• 22 Day Baird D, Garrett TA, Laughlin SK. et al. Short-term change in growth of uterine leiomyoma: tumor growth spurts. Fertil Steril 2011; 95: 242-246
• 23 Baird DD, Patchel SA, Saldana TM. et al. Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans. Am J Obstet Gynecol 2020; 223: 402.e1-402.e18
• 24 Burger HG, Dudley EC, Robertson DM. et al. Hormonal changes in the menopause transition. Recent Prog Horm Res 2002; 57: 257-276
• 25 Ghosh S, Naftalin J, Imrie R. et al. Natural History of Uterine Fibroids: A Radiological Perspective. Curr Obstet Gynecol Rep 2018; 7: 117-121
• 26 Müller A, Thiel F, Binder H. et al. Myome – Teil 1. Geburtshilfe Frauenheilkd 2004; 64: R229-R244
• 27 Müller A, Thiel F, Binder H. et al. Benigne Tumoren. Myome – Entstehung, Diagnostik und Klinik. Geburtshilfe Frauenheilkd 2012; 72: 705-707